BlackRock’s Serina Therapeutics SER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72.5K Buy
11,773
+8,706
+284% +$53.6K ﹤0.01% 4839
2025
Q1
$17.4K Sell
3,067
-505
-14% -$2.86K ﹤0.01% 5062
2024
Q4
$17.9K Hold
3,572
﹤0.01% 5060
2024
Q3
$23.9K Sell
3,572
-406
-10% -$2.72K ﹤0.01% 4867
2024
Q2
$38.1K Buy
3,978
+448
+13% +$4.29K ﹤0.01% 4862
2024
Q1
$47.5K Sell
3,530
-4
-0.1% -$54 ﹤0.01% 4820
2023
Q4
$47.9K Sell
3,534
-218
-6% -$2.95K ﹤0.01% 4900
2023
Q3
$89.7K Buy
3,752
+3
+0.1% +$72 ﹤0.01% 4808
2023
Q2
$118K Buy
3,749
+1
+0% +$31 ﹤0.01% 4778
2023
Q1
$87.4K Sell
3,748
-4
-0.1% -$93 ﹤0.01% 4903
2022
Q4
$72.8K Sell
3,752
-5
-0.1% -$97 ﹤0.01% 5050
2022
Q3
$74K Sell
3,757
-206
-5% -$4.06K ﹤0.01% 5175
2022
Q2
$80K Sell
3,963
-1,537
-28% -$31K ﹤0.01% 5209
2022
Q1
$165K Sell
5,500
-83
-1% -$2.49K ﹤0.01% 5068
2021
Q4
$214K Buy
5,583
+57
+1% +$2.19K ﹤0.01% 5019
2021
Q3
$183K Sell
5,526
-30
-0.5% -$993 ﹤0.01% 4938
2021
Q2
$303K Buy
5,556
+1,246
+29% +$68K ﹤0.01% 4734
2021
Q1
$245K Buy
4,310
+13
+0.3% +$739 ﹤0.01% 4645
2020
Q4
$230K Buy
4,297
+7
+0.2% +$375 ﹤0.01% 4383
2020
Q3
$123K Sell
4,290
-31
-0.7% -$889 ﹤0.01% 4385
2020
Q2
$144K Sell
4,321
-28,195
-87% -$940K ﹤0.01% 4346
2020
Q1
$1.06M Sell
32,516
-736
-2% -$24.1K ﹤0.01% 3780
2019
Q4
$2.13M Buy
33,252
+144
+0.4% +$9.22K ﹤0.01% 3714
2019
Q3
$2.28M Buy
33,108
+913
+3% +$63K ﹤0.01% 3659
2019
Q2
$4.16M Buy
32,195
+15,549
+93% +$2.01M ﹤0.01% 3534
2019
Q1
$2.37M Sell
16,646
-563
-3% -$80.2K ﹤0.01% 3605
2018
Q4
$1.81M Buy
+17,209
New +$1.81M ﹤0.01% 3680